• OPEN AN ACCOUNT
Indian Indices
Sensex
76,909.68 -325.78
( -0.42%)
Global Indices
Nasdaq
53,360.44 -120.34
(-0.23%)
Dow Jones
7,713.14 -52.92
(-0.68%)
Hang Seng
65,335.94 -2,124.79
(-3.15%)
Nikkei 225
10,747.45 19.41
(0.18%)
Forex
USD-INR
95.60 0.07
(0.07%)
EUR-INR
110.76 0.24
(0.21%)
GBP-INR
129.56 0.29
(0.22%)
JPY-INR
0.60 0.00
(0.12%)

EQUITY - MARKET SCREENER

Transgene Biotek Ltd
Industry :  Miscellaneous
BSE Code
ISIN Demat
Book Value()
526139
INE773D01018
-1.2142009
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
21.59
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

Goa Carbon gains after reporting turnaround Q4 performance
May 08,2026

However, revenue from operations jumped 51.13% YoY to Rs 202.61 crore in Q4 FY26, compared with Rs 134.06 crore in the corresponding quarter last year.

The company reported a profit before tax of Rs 4.58 crore in the fourth quarter of FY26, as against a pre-tax loss of Rs 8.19 crore in Q4 FY25.

Total expenses increased 39.19% YoY to Rs 198.02 crore in Q4 FY26. The cost of materials consumed stood at Rs 167.07 crore (up 47.75% YoY), while employee benefits expense was Rs 5.19 crore (down 5.80% YoY) during the period under review.

Goa Carbon is in the business of manufacturing and selling calcined petroleum coke from its manufacturing facilities at Goa, Paradeep and Bilaspur.